Free Republic

s professor of epidemiology at Yale School of Public Health, I have authored over 300 peer-reviewed publications and currently hold senior positions on the editorial boards of several leading journals. I am usually accustomed to advocating for positions within the mainstream of medicine, so have been flummoxed to find that, in the midst of a crisis, I am fighting for a treatment that the data fully support but which, for reasons having nothing to do with a correct understanding of the science, has been pushed to the sidelines. As a result, tens of thousands of patients with COVID-19 are dying...

Harvey Risch says treatment effective in helping people in early stages of disease, especially those with higher risks. Amid the ongoing coronavirus pandemic Yale School of Public Health epidemiology professor Harvey Risch is asserting that the drug hydroxychloroquine, in conjunction with zinc and appropriate antibiotics, can help high-risk patients recover from COVID-19. Risch draws a distinction between two stages of the illness, noting that while the treatment will likely work quickly during the first stage, it is not effective in helping people who have advanced to the more serious second stage. "At the first stage, it is a flu-like illness....